2024
|
Invention
|
Method for inducing cellular immunity through nasal administration. The present disclosure provid... |
|
Invention
|
Vaccine adjuvant composition and use thereof. The present disclosure provides a vaccine adjuvant ... |
|
Invention
|
Nasal delivery device and adapter-coupled suction-type nasal delivery kit including nasal deliver... |
2023
|
Invention
|
Hepatitis b vaccine composition for nasal administration and nasal administration system thereof.... |
2022
|
Invention
|
Vaccine adjuvant agent containing polyacrylic acid polymer and use of same.
The present disclosu... |
|
Invention
|
Vaccine adjuvant agent containing polyacrylic acid polymer and use of same. The present disclosur... |
|
Invention
|
Nasal vaccine-spraying formulation for simultaneously targeting nasal mucosa and nasopharynx.
Th... |
|
Invention
|
Nasal vaccine-spraying formulation for simultaneously targeting nasal mucosa and nasopharynx. The... |
|
Invention
|
Nasal spray/injection nozzle.
A nasal spray/injection nozzle according to one embodiment of the ... |
|
Invention
|
Nasal spray/injection nozzle. A nasal spray/injection nozzle according to one embodiment of the p... |
|
Invention
|
Nasal spray/spout nozzle and nasal rest article for nasal administration.
There is provided a na... |
2021
|
Invention
|
Method for creating multimeric iga antibody, and multispecific multimeric iga antibody.
Provided... |
|
Invention
|
Method for creating multimeric iga antibody, and multispecific multimeric iga antibody. Provided ... |
2020
|
Invention
|
Rhinenchysis composition containing olopatadine.
The present invention relates to a composition ... |
|
Invention
|
Pharmaceutical composition comprising steroid compound and olopatadine.
The present invention re... |
|
Invention
|
Rhinenchysis composition containing olopatadine. The present invention relates to a composition w... |
|
Invention
|
Pharmaceutical composition comprising steroid compound and olopatadine. The present invention rel... |
|
Invention
|
Rhinenchysis composition containing olopatadine. The present invention pertains to: a composition... |
|
Invention
|
Nasal spray/spout nozzle and nasal rest article for nasal administration. There is provided a nas... |
|
Invention
|
Nasal spray injection nozzle and rest product for administration of nasal drops. Provided is a na... |
2019
|
Invention
|
Fluticasone furoate nasal preparation composition. The present invention relates to a pharmaceuti... |
|
Invention
|
Hepatitis b vaccine transnasal administration system. The present invention relates to a rhinovac... |
|
Invention
|
Hepatitis b vaccine transnasal administration system. The present invention relates to a transnas... |
2018
|
Invention
|
Nasal hepatitis b vaccine composition and method for producing same. The present invention relate... |
1994
|
Invention
|
Adhesive patch for percutaneous delivery of isosorbide dinitrate. An adhesive patch for percutane... |
1993
|
Invention
|
Plaster. A percutaneously absorbable plaster containing isosorbide dinitrate (ISDN) which has bee... |
1985
|
Invention
|
Antifungal composition employing pyrrolnitrin in combination with an imidazole compound. This inv... |